Vets reclassify pet obesity as a disease, opening a new clinical market
Veterinary bodies are moving to treat pet obesity as a medical condition rather than a cosmetic issue, separating at-risk animals from those already suffering harm. With around six in ten US dogs and cats overweight or obese, the shift turns weight management into a recurring clinical and commercial opportunity for practices and animal health companies.
Pet obesity is increasingly being treated by veterinary bodies as a disease rather than a cosmetic issue, with excess body fat linked to diabetes, arthritis, cardiovascular strain and shorter lifespans.
The Association for Pet Obesity Prevention (APOP) estimates that 59% of US dogs and 61% of US cats are overweight or obese, based on its most recent clinic survey. It also finds a recognition gap: among owners whose pets scored in the overweight or obese range, nearly a third described their pet as normal, ideal or thin.
Veterinary organisations are now sharpening the definitions. The British Small Animal Veterinary Association (BSAVA) distinguishes between pre-clinical obesity, where a pet carries excess fat but functions normally, and clinical obesity, where mobility, breathing or organ function is already affected. Because excess fat directly causes illness in clinical cases, BSAVA considers clinical obesity a disease in its own right. Telling the two apart requires a veterinary assessment, including history, physical examination and, where needed, blood tests.
The approach mirrors a framework proposed in 2025 by The Lancet Diabetes & Endocrinology Commission for human medicine. APOP has adopted the same categories in its updated 2026 communication guidelines, launched for World Pet Obesity Month this October, which also encourage vets to use person-first language such as “a dog with obesity” to reduce stigma.
For animal health businesses, the shift turns weight management into a recurring clinical and commercial opportunity. A disease-based framework supports structured diagnosis, prescription diets, monitoring and follow-up care, and could strengthen the case for future pharmaceutical treatments. APOP is collecting new prevalence data through 31 December, which should give an updated picture of pet obesity next year.
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."